FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224882539> ?p ?o ?g. }

• W4224882539 endingPage "102839" @default.
• W4224882539 startingPage "102839" @default.
• W4224882539 abstract "Diarrhea predominant irritable bowel syndrome (IBS) is a highly relapsing gastrointestinal disorder decreasing the quality of life. Existing studies indicated that the therapeutic effects maintained for a period of time after the treatments were discontinued (post-treatment therapeutic effects or PTTE). In this study, we aim to assess the PTTE of tongxie. We performed a multiple center, controlled, double blind study of patients with IBS randomized to tongxie (n = 120) or placebo (n = 120) for 4 weeks and followed up for 57 weeks. The primary outcomes were abdominal pains and stool consistency. The secondary outcomes were pain frequency and stool frequency. Tertiary outcomes were adverse effects and global overall symptom. The outcome data were collected at days 1, 2, 3, weeks 1 and 4 during the treatment and at days 1, 2, 3, until week 57 during the post-treatment. Significantly more patients receiving tongxie were clinical responders to the primary and secondary endpoints from day 1 until the end of the treatment. The positive effects of tongxie were maintained until 17-25 weeks after tongxie was discontinued. The relapse-free probabilities in the tongxie group were significantly higher than those in the placebo group (P < .001). Twenty-five weeks after the therapies were discontinued could be considered as IBS natural history. During this period, an average of 53.8-56.3% of patients (pool tongxie and placebo data together) had IBS symptoms (pain scale ≥ 3, stool consistency ≥ 5). In particular, at the end of this study (week 61), 145 (54.2%) patients had IBS symptoms. Our results provide clinical insights into efficient and cost-effective management of refractory IBS, and lend support to the IBS management that the selection of a therapy should consider both its effectiveness during treatment and its PTTE after the treatment." @default.
• W4224882539 created "2022-04-27" @default.
• W4224882539 creator A5001464751 @default.
• W4224882539 creator A5010444377 @default.
• W4224882539 creator A5014869660 @default.
• W4224882539 creator A5014942240 @default.
• W4224882539 creator A5015808792 @default.
• W4224882539 creator A5018476892 @default.
• W4224882539 creator A5022517515 @default.
• W4224882539 creator A5023362192 @default.
• W4224882539 creator A5030978586 @default.
• W4224882539 creator A5039070819 @default.
• W4224882539 creator A5042376090 @default.
• W4224882539 creator A5043350524 @default.
• W4224882539 creator A5048419560 @default.
• W4224882539 creator A5048649316 @default.
• W4224882539 creator A5059068739 @default.
• W4224882539 creator A5065418938 @default.
• W4224882539 creator A5071597724 @default.
• W4224882539 creator A5077190393 @default.
• W4224882539 creator A5080611223 @default.
• W4224882539 creator A5084745904 @default.
• W4224882539 creator A5084803961 @default.
• W4224882539 date "2022-09-01" @default.
• W4224882539 modified "2023-09-25" @default.
• W4224882539 title "Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial" @default.
• W4224882539 cites W1967873913 @default.
• W4224882539 cites W1997297098 @default.
• W4224882539 cites W2001338783 @default.
• W4224882539 cites W2002324192 @default.
• W4224882539 cites W2002820787 @default.
• W4224882539 cites W2017740517 @default.
• W4224882539 cites W2018343808 @default.
• W4224882539 cites W2024915348 @default.
• W4224882539 cites W2047421259 @default.
• W4224882539 cites W2056304431 @default.
• W4224882539 cites W2064433763 @default.
• W4224882539 cites W2075272700 @default.
• W4224882539 cites W2083325871 @default.
• W4224882539 cites W2085009106 @default.
• W4224882539 cites W2088374316 @default.
• W4224882539 cites W2103771013 @default.
• W4224882539 cites W2121519021 @default.
• W4224882539 cites W2146147731 @default.
• W4224882539 cites W2146167423 @default.
• W4224882539 cites W2149072553 @default.
• W4224882539 cites W2171309016 @default.
• W4224882539 cites W2398951260 @default.
• W4224882539 cites W2434465951 @default.
• W4224882539 cites W2515209924 @default.
• W4224882539 cites W2563526751 @default.
• W4224882539 cites W2591394959 @default.
• W4224882539 cites W2625528543 @default.
• W4224882539 cites W2741548298 @default.
• W4224882539 cites W2805556088 @default.
• W4224882539 cites W2810026625 @default.
• W4224882539 cites W2887901126 @default.
• W4224882539 cites W2972738650 @default.
• W4224882539 cites W2988055268 @default.
• W4224882539 cites W2990029068 @default.
• W4224882539 cites W4367153406 @default.
• W4224882539 doi "https://doi.org/10.1016/j.ctim.2022.102839" @default.
• W4224882539 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35483627" @default.
• W4224882539 hasPublicationYear "2022" @default.
• W4224882539 type Work @default.
• W4224882539 citedByCount "2" @default.
• W4224882539 countsByYear W42248825392023 @default.
• W4224882539 crossrefType "journal-article" @default.
• W4224882539 hasAuthorship W4224882539A5001464751 @default.
• W4224882539 hasAuthorship W4224882539A5010444377 @default.
• W4224882539 hasAuthorship W4224882539A5014869660 @default.
• W4224882539 hasAuthorship W4224882539A5014942240 @default.
• W4224882539 hasAuthorship W4224882539A5015808792 @default.
• W4224882539 hasAuthorship W4224882539A5018476892 @default.
• W4224882539 hasAuthorship W4224882539A5022517515 @default.
• W4224882539 hasAuthorship W4224882539A5023362192 @default.
• W4224882539 hasAuthorship W4224882539A5030978586 @default.
• W4224882539 hasAuthorship W4224882539A5039070819 @default.
• W4224882539 hasAuthorship W4224882539A5042376090 @default.
• W4224882539 hasAuthorship W4224882539A5043350524 @default.
• W4224882539 hasAuthorship W4224882539A5048419560 @default.
• W4224882539 hasAuthorship W4224882539A5048649316 @default.
• W4224882539 hasAuthorship W4224882539A5059068739 @default.
• W4224882539 hasAuthorship W4224882539A5065418938 @default.
• W4224882539 hasAuthorship W4224882539A5071597724 @default.
• W4224882539 hasAuthorship W4224882539A5077190393 @default.
• W4224882539 hasAuthorship W4224882539A5080611223 @default.
• W4224882539 hasAuthorship W4224882539A5084745904 @default.
• W4224882539 hasAuthorship W4224882539A5084803961 @default.
• W4224882539 hasBestOaLocation W42248825391 @default.
• W4224882539 hasConcept C102652120 @default.
• W4224882539 hasConcept C126322002 @default.
• W4224882539 hasConcept C142724271 @default.
• W4224882539 hasConcept C159110408 @default.
• W4224882539 hasConcept C168563851 @default.
• W4224882539 hasConcept C197934379 @default.
• W4224882539 hasConcept C204787440 @default.
• W4224882539 hasConcept C27081682 @default.

• next